Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You bet, lol.
Let'see...as of today:
1) no news on the publication about L;
2) no news on the publication about D;
3) no news on the interim blinded data;
4) no news on final or topline for PFS;
5) no news on 233 OS mark reached;
6) no news on any kind of partnership that could bring in any upfront money.
Put up your order and you will see.
Then you should know that almost in every regulated markets around the globe MM are forced by regulations to put up a bid and a ask untill options expire.
Absolutely untrue. Sorry but if you say so that means IMO that you don't trade options or you would know.
Shares for shares, not warrants or convertible notes as collateral. You need shares to cover a short on shares.
That's exactly how it usually works when they are illiquid for strike price reasons.
Welcome back. We missed you.
Imo doesn't look good, does it?
I agreed with the fact that ppl are tossing nonsense numbers. My whole post seemed clear enough to me. The reason why you try to argue on anything is beyond me and honestly can't help it. Will live with that.
This is my personal view:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=135582577
Good for you.
Long post to mean that you agree with my own estimates on possible valuation in case l would be approved?
I agree. The last time I saw total market for GBM divided by O/S I fell out of the chair. There are lots of people in this message board that don't have a clue about finance.
Nice read.
That's why in a recent post I made a very clear personal assumption on potential price given some conditions. You can go check that if interested .
Either way, this should IMO be made public.
Who talked about word games? I only said they are two different terms. And yes, I do agree at this point interim might be released soon, but it's now almost and yet one month and a half after announcement...
That's not what I am talking about. The 0.98 was the average strike price of warrants. Outstanding warrants, if memory serves me well, are about 120M. So even if the price will spike above 1 and all warrants will be exercised, the amount of money that will be brought in is way less than the one you are reporting.
Right, but that 0.98 median was only for warrants, not all PDS.
Ditto, that's it. Thank you for sharing.
Where did you get the 192M number?
If a CEO had a master checklist of what is needed to be accomplished for putting together a major company to take a product to approval and the market, wouldn't you think that not only would it have been planned out long ago but we are right on target to achieve it when considering where Lp has taken NWBO.
No other SOC does this and this fact happens to be the the new IT product
You think he couldn't have gotten out as the PPS crept down from $12 to .16, come on, believe that he could have thrown in the towel at multiple price points
To me that is a no brainer
No, anticipating and soon is not the same at all, this is clear to anyone I hope, for those people who don't understand the differnce I suggest improved english lessons.
Even if the trial actually worked and is approvable, approval is not till 2019.
Here is a prediction we can all measure in the next 6 months.
Prior to any hypothetical BLA submission to the FDA (which is the first step in approval), we see:
. Either R/S or an authorized share vote increase this year.
. With the new shares, heavy dilution. Another 300-400 million shares plus warrants by spring '18.
Feel free to slam this all you want. Keep it civil though, would like to be able to match up replies to actual events next May.
Maybe even conservative! LOL.
After how many R/S?
An interesting read:
https://cancer.ucla.edu/news-events/newsroom/researcher-spotlights/linda-liau
Especially when there's the question: Is the vaccine working?
Question: in the recent UCLA update on OS:
http://www.neurooncology.ucla.edu/performance/glioblastomamultiforme.aspx
There are a 587 total of treated grp listed, within the age 18-93 since 11/04/2010. Of these population 109 are in the age range 70-93, leaving 478 patients in the age range 18-70, which is the age range that was used as for the eligible patients in the PIII L trial.
Does anyone know, how many patients were treated at UCLA since 11/04/2010 in all DcVax trials combined?
I agree with this view.
they certainly do seem to put DCVAX at the forefront of their treatment offerings
I hope this is not the publication investors were waiting for...
I suspect news AH.
Add that to the calendar!!!
If news won't come in the very next following days, I will agree with you that I would expect the worse. Besides all, we're also still waiting for a publication announced 5 (five!) months ago.
Ppl have said that for the latest nth fridays, lol.
Do you mind to start listing ASCO 2018? Thanks.